Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Sydney, July 31, 2007 (ABN Newswire) - Stirling Products Limited (ASX: STI) - Activities Update - Dr Calvin London, MD; Stirling Products Limited (ASX: STI) present the following audio webcast regarding "Activities Update". You may also download this audio webcast to your computer or portable audio player.
This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
ASX: STI STIRLING PRODUCTS LIMITED Level 11, BGC Centre , 28 The Esplanade PERTH WA 6000 08 9480 1480 Fax 08 9226 4144
Commercialising patented beta agonist Repartitioning Feed Enhancers ('RFEs') for livestock, which are being positioned as replacement products and alternatives to the use of antibiotics and hormones as growth promoters.Non Exec. Director: Mr Gary Waters Managing Director: Dr Calvin London Non Exec. Chairman, Non Exec. Director: Prof. Clive P Page
